Research progress on aging-related secretory phenotype and development of anti-aging drugs

Authors

  • JingYao Zhao Capital Medical University Author

DOI:

https://doi.org/10.64135/d6vw0d55

Keywords:

secretory phenotype related to aging, Aging cell eliminator, Aging morphology regulating agent, Anti-aging drugs, Secretome

Abstract

Abstract:Aging-related secretory phenotype (SASP) is a complex combination of factors secreted by aging cells, including cytokines, chemokines, growth factors and proteases, which play a key role in aging and the development of corresponding diseases. In recent years, studies have shown that SASP participates in intercellular communication through autocrine and paracrine mechanisms, which not only causes inflammation and fibrosis of local tissues, but also drives systemic aging as a whole. In this review, the molecular composition, regulatory mechanism and biological function of SASP are systematically summarized, and the development methods of anti-aging drugs targeting SASP are emphatically discussed, including removing aging cells, inhibiting the release of SASP and intervening aging-related signal pathways. The challenges and future development trends in this field are also prospected, which provides theoretical evidence for developing new anti-aging intervention approaches.

References

[1] Kong Zhengyi, Chujun Li, Yan Qingfeng. Research progress of mitochondria regulating aging-related secretory phenotype [J]. China Journal of Cell Biology, 2025,47(08):2020-2031.

[2] Lee J ,Oh J ,Kim R J , et al. Cabozantinib, an Anti-Aging Agent, Prevents Bone Loss in Estrogen-Deficient Mice by Suppressing Senescence-Associated Secretory Phenotype Factors[J].International Journal of Molecular Sciences,2025,26(15):7123-7123.

[3] Pang Bingyu. The role of aging-related secretory phenotype of skin vascular endothelial cells in the pathogenesis of psoriasis [D]. PLA Air Force Medical University, 2025.

[4] Zeng Chenye, Hua Rui, Mark Wang. The strategy of eliminating aging cells and the application of CAR cell therapy in anti-aging therapy [J]. China Journal of Biochemistry and Molecular Biology, 2024,40(09):1197-1204.

[5] Sun Yu. The pathophysiological significance of cell aging and the development prospect of new anti-aging drugs [J]. acta physiologica sinica, 2023,75(06):847-863.

[6] Jiaxing S ,Yu G ,Shenghua Z , et al. Unlocking the Secrets of Aging: Epigenetic Reader BRD4 as the Target to Combatting Aging-Related Diseases.[J].Journal of advanced research,2023, 63:207-218.

[7] Wenzheng X ,Bowen C ,Liqun L , et al. MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling.[J].Aging, 2021, 13:131-140.

[8] Yang Yihui, Ren Liwen, Zheng Xiangjin, et al. Research progress of anti-aging targets and drugs [J]. China Journal of Pharmacy, 2021,56(16):1282-1290.

Downloads

Published

2026-06-23

How to Cite

Research progress on aging-related secretory phenotype and development of anti-aging drugs. (2026). Advances in Life Science for Adolescents, 2(2). https://doi.org/10.64135/d6vw0d55